Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment-Reference-Cited by-同舟云学术

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment

Published:2002-03-07 Issue:3 Volume:98 Page:409-414
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Scheibenbogen Carmen,Sun Yuansheng,Keilholz Ulrich,Song Mingxia,Stevanovic Stefan,Asemissen Anne Marie,Nagorsen Dirk,Thiel Eckhard,Rammensee Hans-Georg,Schadendorf Dirk

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

2. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

3. Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes;Cancer Immunology, Immunotherapy;2016-09-06

2. Spontaneous presence of FOXO3-specific T cells in cancer patients;OncoImmunology;2014-08-03

3. HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients;Cancer Research;2013-01-17

4. Characterization of T-cell responses against IκBα in cancer patients;OncoImmunology;2012-11

5. Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot;Cells;2012-04-26